Medicinal Product, Dietary Supplement, Medical Device – Differences in Their Meaning

In accordance with the provisions of the Pharmaceutical Law of 6 September 2001 (Article 2, point 32), a medicinal product—more precisely termed a pharmaceutical preparation—is legally defined as a single substance or a combination of substances attributed with the capacity to: prevent or treat diseases affecting humans and animals, be administered for diagnostic purposes, or restore, enhance, or modify physiological functions of the organism through pharmacological, metabolic, or immunological mechanisms of action. Polish pharmaceutical legislation further distinguishes several specialized categories of medicinal products, including pharmacy-only medicines, extemporaneous preparations, veterinary drugs, orphan medicinal products, pediatric formulations, and advanced therapy medicinal products. Within commercial distribution, three primary accessibility classifications exist: over-the-counter (OTC) medicines (available without prescription), prescription-only (Rx) medicines, and products authorized for non-pharmacy retail sale, which may be purchased in venues such as drugstores, grocery stores, or newsstands. The registration and market authorization process for a medicinal product is highly intricate, multi-phase, and preceded by rigorous clinical trials. Regulatory oversight of the pharmaceutical market in Poland is exercised by the Main Pharmaceutical Inspectorate (Główny Inspektorat Farmaceutyczny, GIF) and the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, URPL). Every medicinal product must be accompanied by a mandatory Summary of Product Characteristics (SPC), a comprehensive document detailing therapeutic indications, dosing regimens, safety profiles, potential interactions with other substances, and adverse effect data.

The legal framework for medical devices is established in the Medical Devices Act dated 20 May 2010 (Article 2, Section 1, Point 38), which defines them as a diverse category encompassing surgical instruments, diagnostic equipment, specialized software applications, biomedical materials, and therapeutic or preventive preparations. This classification includes, but is not limited to, dental prostheses, orthopedic stabilization devices, antiseptic wound-care solutions, vascular catheters, facial protective masks, injection kits, surgical blades, compression bandages, mobility assistance devices (e.g., wheelchairs), vital sign monitoring equipment (such as sphygmomanometers), and inhalers used in the management of respiratory conditions like asthma. Notably, some medical devices may superficially resemble medicinal products—particularly in liquid formulations such as syrups or drops. The fundamental distinction between a medicinal product and a medical device lies in their mode of action: medical devices primarily exert physical effects (e.g., surface disinfection prevents infectious complications), whereas medicinal products demonstrate pharmacological, immunological, or metabolic activity, directly modulating the body’s biochemical pathways.

Pursuant to the provisions set forth in the Law of 25 August 2006 on Food Safety and Nutrition—specifically Article 3, Section 3, Point 39—a **dietary supplement** is classified as a food product expressly designed to augment the standard diet by providing concentrated doses of vitamins, minerals, or other bioactive compounds that demonstrate a documented nutritional or physiological effect. It is **critical to emphasize** that these preparations **do not possess therapeutic properties** and must not be regarded as replacements for a balanced diet or pharmacological treatment. Key distinctions between dietary supplements and medicinal products include: (1) **regulatory oversight**—supplements fall under the jurisdiction of the Chief Sanitary Inspectorate (GIS), whereas medicines are subject to stringent evaluation by the Office for Registration of Medicinal Products; (2) **market authorization procedures**—supplements require no formal registration, only a notification to the GIS by the manufacturer, significantly expediting their commercial availability; (3) **absence of mandatory clinical trials** prior to market release, a requirement that is non-negotiable for pharmaceuticals. These streamlined regulations, however, introduce a heightened risk of irregularities, such as microbial contamination, inaccurate ingredient labeling, or substandard raw material quality. The reduced production costs often correlate with less rigorous quality assurance measures, potentially compromising both the efficacy and safety of the supplements.

The legal framework governing this category of products is established in the Act of 25 August 2006 on Food Safety and Nutrition — specifically within Article 3, Section 3, Item 43 — which defines *foodstuffs for special use* as nutritional products distinguished by their intentionally formulated composition or distinctive processing methods, setting them apart from conventional foods widely consumed by the general population. These specialized products are introduced to the marketplace with the primary objective of addressing the unique dietary requirements of individuals experiencing impairments in digestive functionality or metabolic dysregulation. Their consumption may yield measurable health benefits owing to the inclusion of carefully calibrated bioactive components, the controlled intake of which is justified by the consumer’s specific physiological condition. Representative examples within this classification include: gluten-free foodstuffs designed for individuals with celiac disease or non-celiac gluten sensitivity, lactose-free products intended for those with lactose intolerance, infant formulas with precisely balanced nutritional profiles, low-sodium or sodium-free items tailored for hypertensive patients, and medical-purpose dietary foods administered under clinical supervision. The principal consumer demographic for these products comprises individuals managing chronic conditions such as diabetes mellitus, oncological disorders, or renal diseases, as well as postoperative patients, elderly persons with dysphagia, and those requiring targeted nutritional support during critical care interventions.

As established by expert consensus in 1998, functional foods—by virtue of their physiologically active constituents—demonstrate scientifically substantiated health benefits that extend beyond basic nutritional provision. To qualify under this classification, products must adhere to a rigorous set of criteria. Primarily, their physical presentation must align with conventional food items and integrate seamlessly into standard dietary patterns, thereby excluding formats such as encapsulated supplements, powders, or liquid extracts. Furthermore, beyond their inherent nutritional profile, these products must either exhibit an elevated concentration of a specific bioactive compound or be fortified with additional ingredients not originally present. The consumption of such foods should empirically contribute to enhanced physical and cognitive well-being, mitigate disease risk factors, or augment therapeutic outcomes, thereby elevating overall quality of life. All health-related claims must be substantiated by robust clinical trials conducted on human populations, employing methodologies that ensure statistical significance, independent verification, and sufficient duration. Notably, functional foods encompass more than mere compositional adjustments; manufacturing processes may also involve the removal of deleterious components or the enhancement of nutrient bioavailability. The functional spectrum of these products is diverse and composition-dependent: lactose-free dairy caters to individuals with intolerance, calcium-magnesium-fortified beverages support osteoporosis prevention, isotonic sports drinks with added vitamins and minerals boost psychophysical endurance, and probiotic-enriched yogurts promote gastrointestinal health through microbial balance.